July/August 2025: Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhoea (EAGLE-1): A Phase 3 Randomised, Open-label, Non-inferiority, Multicentre Study

Mexico

July/August 2025: Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhoea (EAGLE-1): A Phase 3 Randomised, Open-label, Non-inferiority, Multicentre Study

Aug 12, 2025

Article and Study Summary: Article: Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study Published in: Lancet. 2025;405(10489):1608–1620....

Mexico

July/August 2025: Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhoea (EAGLE-1): A Phase 3 Randomised, Open-label, Non-inferiority, Multicentre Study

Enter keyword:

Select a category:

Select a tag:

Select a location:

Now on Bluesky

Now on Bluesky